MFT
MRNA icon

Moisand Fitzgerald Tamayo’s Moderna MRNA Stock Holding History

Moisand Fitzgerald Tamayo’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-100
Closed -$10.3K – 758
2023
Q3 		$10.3K Buy
100
+86
+614% +$9.59K ﹤0.01% 333
2023
Q2 		$1.7K Hold
14
– – ﹤0.01% 573
2023
Q1 		$2.15K Sell
14
-1
-7% -$165 ﹤0.01% 544
2022
Q4 		$2.69K Buy
15
+14
+1,400% +$2.29K ﹤0.01% 500
2022
Q3 		$0 Hold
1
– – ﹤0.01% 803
2022
Q2 		$0 Buy
+1
New +$143 ﹤0.01% 641
2022
Q1 		– Sell
-1
Closed – – 595
2021
Q4 		$0 Sell
1
-2
-67% -$585 ﹤0.01% 401
2021
Q3 		$1K Hold
3
– – ﹤0.01% 356
2021
Q2 		$1K Hold
3
– – ﹤0.01% 390
2021
Q1 		$0 Hold
3
– – ﹤0.01% 387
2020
Q4 		$0 Buy
+3
New +$304 ﹤0.01% 373

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Moisand Fitzgerald Tamayo's MRNA Position: Q4 2023 in Review

Moisand Fitzgerald Tamayo sold out of Moderna (MRNA) in Q4 2023, closing a stake of 100 shares — an estimated $10.3K sold.

Moisand Fitzgerald Tamayo first reported a position in MRNA in Q4 2020 and held it in 11 quarters. The position peaked at $10.3K in Q3 2023. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Moisand Fitzgerald Tamayo reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Moisand Fitzgerald Tamayo sold 100 Moderna shares in Q4 2023, an estimated $10.3K.
  • Moisand Fitzgerald Tamayo first reported a position in Moderna in Q4 2020 and held it in 11 quarters.
  • Moisand Fitzgerald Tamayo's Moderna position peaked at $10.3K in Q3 2023.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Moisand Fitzgerald Tamayo's 13F filing for Q4 2023, filed 18 Jan 2024.